![1]()
News
Health sector has spent $464 million on lobbying in 2020
November 2, 2020
PhRMA leads sector through the third quarter, with the American Hospital Association just behind.
News
CDC panel takes on COVID vaccine rollout, risks, and side effects
November 2, 2020
ACIP will need to offer direction on which groups should get priority in vaccine allocation, inasmuch as early supplies will not be sufficient to vaccinate everyone.
News
Chinese American families suffer discrimination related to COVID-19
October 29, 2020
In a sample of Chinese American parents and children, reports of racial discrimination during the pandemic were common.
News
COVID spikes exacerbate health worker shortages in Rocky Mountains, Great Plains
October 26, 2020
“One case can take out a whole team of people in a blink of an eye.”
News
Florida will investigate all COVID-19 deaths
October 23, 2020
The review is meant to “ensure data integrity.”
![1]()
News
COVID-19 vaccine standards questioned at FDA advisory meeting
October 23, 2020
Speakers asked for data showing COVID-19 vaccines can prevent serious illness and urged transparency about the agency’s deliberations for each product to be considered.
![1]()
News
Patients can read your clinical notes starting Nov. 2
October 22, 2020
“Open notes” mandates immediate patient access to inpatient and outpatient notes and testing and imaging results.
News
CDC flips, acknowledges aerosol spread of COVID-19
October 6, 2020
The update acknowledges the existence of some published reports showing limited, uncommon circumstances where people with COVID-19 infected others who were more than 6 feet away or shortly after the COVID-19–positive person left an area.
News
Inside the flawed White House testing scheme that did not protect Trump
October 5, 2020
An early antigen test used by the White House was woefully inaccurate. But the new antigen test the White House is using has not been independently evaluated for accuracy and reliability.
News
‘Celebration’ will be ‘short-lived’ if COVID vaccine rushed: Experts
October 2, 2020
US regulators eventually could safely approve vaccines for COVID-19 if the process is kept free of political pressure regarding time lines, study protocols, and safety standards, expert witnesses told a House panel investigating the process.
